677 related articles for article (PubMed ID: 6294182)
61. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
Bukowski JF; Biron CA; Welsh RM
J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
[TBL] [Abstract][Full Text] [Related]
62. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice.
Sharma BS; Mhaskar S; Balazs L; Siaw M
Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650
[TBL] [Abstract][Full Text] [Related]
63. Sendai virus-specific T cell clones II. Induction of interferon production by Sendai virus-specific T helper cell clones.
Ertl HC; Brown EG; Finberg RW
Eur J Immunol; 1982 Dec; 12(12):1051-3. PubMed ID: 6297920
[TBL] [Abstract][Full Text] [Related]
64. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
Ostensen ME; Thiele DL; Lipsky PE
J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514
[TBL] [Abstract][Full Text] [Related]
65. Cytokines involved in the augmentation of murine natural killer cell activity by pyrimidinones in vivo.
Richard KA; Mortensen RF; Tracey DE
J Biol Response Mod; 1987 Dec; 6(6):647-63. PubMed ID: 2453616
[TBL] [Abstract][Full Text] [Related]
66. Reduced interferon-gamma secretion by natural killer cells from rats susceptible to postviral chronic airway dysfunction.
Mikus LD; Rosenthal LA; Sorkness RL; Lemanske RF
Am J Respir Cell Mol Biol; 2001 Jan; 24(1):74-82. PubMed ID: 11152653
[TBL] [Abstract][Full Text] [Related]
67. Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation.
Sayers TJ; Mason AT; Ortaldo JR
J Immunol; 1986 Mar; 136(6):2176-80. PubMed ID: 3081640
[TBL] [Abstract][Full Text] [Related]
68. Modulation of CD3- large granular lymphocyte functions by agonist and antagonists of protein kinase C: effects on NK and lymphokine-activated killer activity and production of IFN-gamma.
Ortaldo JR; Young HA; Varesio L
J Immunol; 1989 Jul; 143(1):366-71. PubMed ID: 2543702
[TBL] [Abstract][Full Text] [Related]
69. In vivo activation of murine natural killer cell functions by human recombinant DNA interleukin 2.
Sayers T; Rossiter H; Chung J; Hren A; Armerding D
Immunobiology; 1985 Apr; 169(3):303-18. PubMed ID: 3922876
[TBL] [Abstract][Full Text] [Related]
70. Genetic control of the natural killer cell activity in SJL and other strains of mice.
Kaminsky SG; Nakamura I; Cudkowicz G
J Immunol; 1985 Jul; 135(1):665-71. PubMed ID: 3923115
[TBL] [Abstract][Full Text] [Related]
71. Interaction between cytokines and 8-mercaptoguanosine in humoral immunity: synergy with interferon.
Goodman MG
J Immunol; 1987 Jul; 139(1):142-6. PubMed ID: 3108396
[TBL] [Abstract][Full Text] [Related]
72. Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicity.
Gersuk GM; Chang WC; Pattengale PK
J Immunol; 1988 Dec; 141(11):4031-8. PubMed ID: 2846698
[TBL] [Abstract][Full Text] [Related]
73. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
Shitara K; Ichimura O; Mitsuno T; Osawa T
J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
[TBL] [Abstract][Full Text] [Related]
74. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
Okabe M; Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
[TBL] [Abstract][Full Text] [Related]
75. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
[TBL] [Abstract][Full Text] [Related]
76. Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro.
Ujiie T
Jpn J Exp Med; 1987 Dec; 57(6):333-8. PubMed ID: 3131563
[TBL] [Abstract][Full Text] [Related]
77. Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2.
Svedersky LP; Shepard HM; Spencer SA; Shalaby MR; Palladino MA
J Immunol; 1984 Aug; 133(2):714-8. PubMed ID: 6203975
[TBL] [Abstract][Full Text] [Related]
78. Effects of biological response modifiers on lung natural killer activity.
Lauzon W; Lemaire I
Immunopharmacol Immunotoxicol; 1991; 13(3):237-50. PubMed ID: 1719060
[TBL] [Abstract][Full Text] [Related]
79. [Role of interleukin 2 and interferon gamma in induction of activated natural killer cells by the streptococcal preparation OK432].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2504-12. PubMed ID: 2515233
[TBL] [Abstract][Full Text] [Related]
80. Comparative analysis of natural killer function in lung, spleen, and peripheral blood lymphocytes: evidence of differential characteristics.
Lauzon W; Yang H; Lemaire I
Reg Immunol; 1990-1991; 3(3):145-50. PubMed ID: 2129104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
